BACKGROUND: It is uncertain whether evidence supports routinely estimating a postmenopausal woman's risk of breast cancer and intervening to reduce risk. METHODS: We systematically reviewed prospective studies about models and sex hormone levels to assess breast cancer risk and used meta-analysis with random effects models to summarize the predictive accuracy of breast density. We also reviewed prospective studies of the effects of exercise, weight management, healthy diet, moderate alcohol consumption, and fruit and vegetable intake on breast cancer risk, and used random effects models for a meta-analyses of tamoxifen and raloxifene for primary prevention of breast cancer. All studies reviewed were published before June 2008, and all statistical tests were two-sided. RESULTS: Risk models that are based on demographic characteristics and medical history had modest discriminatory accuracy for estimating breast cancer risk (c-statistics range = 0.58-0.63). Breast density was strongly associated with breast cancer (relative risk [RR] = 4.03, 95% confidence interval [CI] = 3.10 to 5.26, for Breast Imaging Reporting and Data System category IV vs category I; RR = 4.20, 95% CI = 3.61 to 4.89, for >75% vs <5% of dense area), and adding breast density to models improved discriminatory accuracy (c-statistics range = 0.63-0.66). Estradiol was also associated with breast cancer (RR range = 2.0-2.9, comparing the highest vs lowest quintile of estradiol, P < .01). Most studies found that exercise, weight reduction, low-fat diet, and reduced alcohol intake were associated with a decreased risk of breast cancer. Tamoxifen and raloxifene reduced the risk of estrogen receptor-positive invasive breast cancer and invasive breast cancer overall. CONCLUSIONS: Evidence from this study supports screening for breast cancer risk in all postmenopausal women by use of risk factors and breast density and considering chemoprevention for those found to be at high risk. Several lifestyle changes with the potential to prevent breast cancer should be recommended regardless of risk.
BACKGROUND: It is uncertain whether evidence supports routinely estimating a postmenopausal woman's risk of breast cancer and intervening to reduce risk. METHODS: We systematically reviewed prospective studies about models and sex hormone levels to assess breast cancer risk and used meta-analysis with random effects models to summarize the predictive accuracy of breast density. We also reviewed prospective studies of the effects of exercise, weight management, healthy diet, moderate alcohol consumption, and fruit and vegetable intake on breast cancer risk, and used random effects models for a meta-analyses of tamoxifen and raloxifene for primary prevention of breast cancer. All studies reviewed were published before June 2008, and all statistical tests were two-sided. RESULTS: Risk models that are based on demographic characteristics and medical history had modest discriminatory accuracy for estimating breast cancer risk (c-statistics range = 0.58-0.63). Breast density was strongly associated with breast cancer (relative risk [RR] = 4.03, 95% confidence interval [CI] = 3.10 to 5.26, for Breast Imaging Reporting and Data System category IV vs category I; RR = 4.20, 95% CI = 3.61 to 4.89, for >75% vs <5% of dense area), and adding breast density to models improved discriminatory accuracy (c-statistics range = 0.63-0.66). Estradiol was also associated with breast cancer (RR range = 2.0-2.9, comparing the highest vs lowest quintile of estradiol, P < .01). Most studies found that exercise, weight reduction, low-fat diet, and reduced alcohol intake were associated with a decreased risk of breast cancer. Tamoxifen and raloxifene reduced the risk of estrogen receptor-positive invasive breast cancer and invasive breast cancer overall. CONCLUSIONS: Evidence from this study supports screening for breast cancer risk in all postmenopausal women by use of risk factors and breast density and considering chemoprevention for those found to be at high risk. Several lifestyle changes with the potential to prevent breast cancer should be recommended regardless of risk.
Authors: Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark Journal: JAMA Date: 2006-06-05 Impact factor: 56.272
Authors: Celia Patricia Kaplan; Jennifer S Haas; Eliseo J Pérez-Stable; Steven E Gregorich; Carol Somkin; Genevieve Des Jarlais; Karla Kerlikowske Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-01 Impact factor: 4.254
Authors: A Heather Eliassen; Graham A Colditz; Bernard Rosner; Walter C Willett; Susan E Hankinson Journal: JAMA Date: 2006-07-12 Impact factor: 56.272
Authors: Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger Journal: N Engl J Med Date: 2006-07-13 Impact factor: 91.245
Authors: Jane Key; Susan Hodgson; Rumana Z Omar; Tina K Jensen; Simon G Thompson; Alan R Boobis; Donald S Davies; Paul Elliott Journal: Cancer Causes Control Date: 2006-08 Impact factor: 2.506
Authors: Rachael Z Stolzenberg-Solomon; Shih-Chen Chang; Michael F Leitzmann; Karen A Johnson; Christine Johnson; Saundra S Buys; Robert N Hoover; Regina G Ziegler Journal: Am J Clin Nutr Date: 2006-04 Impact factor: 7.045
Authors: Jan Novotny; Ladislav Pecen; Lubos Petruzelka; Adam Svobodnik; Ladislav Dusek; Jan Danes; Miloslava Skovajsova Journal: Breast Cancer Res Treat Date: 2005-12-01 Impact factor: 4.872
Authors: Ross L Prentice; Bette Caan; Rowan T Chlebowski; Ruth Patterson; Lewis H Kuller; Judith K Ockene; Karen L Margolis; Marian C Limacher; JoAnn E Manson; Linda M Parker; Electra Paskett; Lawrence Phillips; John Robbins; Jacques E Rossouw; Gloria E Sarto; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Linda Van Horn; Mara Z Vitolins; Jean Wactawski-Wende; Robert B Wallace; Sylvia Wassertheil-Smoller; Evelyn Whitlock; Katsuhiko Yano; Lucile Adams-Campbell; Garnet L Anderson; Annlouise R Assaf; Shirley A A Beresford; Henry R Black; Robert L Brunner; Robert G Brzyski; Leslie Ford; Margery Gass; Jennifer Hays; David Heber; Gerardo Heiss; Susan L Hendrix; Judith Hsia; F Allan Hubbell; Rebecca D Jackson; Karen C Johnson; Jane Morley Kotchen; Andrea Z LaCroix; Dorothy S Lane; Robert D Langer; Norman L Lasser; Maureen M Henderson Journal: JAMA Date: 2006-02-08 Impact factor: 56.272
Authors: John J Heine; Christopher G Scott; Thomas A Sellers; Kathleen R Brandt; Daniel J Serie; Fang-Fang Wu; Marilyn J Morton; Beth A Schueler; Fergus J Couch; Janet E Olson; V Shane Pankratz; Celine M Vachon Journal: J Natl Cancer Inst Date: 2012-07-03 Impact factor: 13.506
Authors: Rosa Anna DeFilippis; Hang Chang; Nancy Dumont; Joseph T Rabban; Yunn-Yi Chen; Gerald V Fontenay; Hal K Berman; Mona L Gauthier; Jianxin Zhao; Donglei Hu; James J Marx; Judy A Tjoe; Elad Ziv; Maria Febbraio; Karla Kerlikowske; Bahram Parvin; Thea D Tlsty Journal: Cancer Discov Date: 2012-07-09 Impact factor: 39.397
Authors: Ghada N Farhat; Neeta Parimi; Rowan T Chlebowski; Joann E Manson; Garnet Anderson; Alison J Huang; Eric Vittinghoff; Jennifer S Lee; Andrea Z Lacroix; Jane A Cauley; Rebecca Jackson; Deborah Grady; Dorothy S Lane; Lawrence Phillips; Michael S Simon; Steven R Cummings Journal: J Natl Cancer Inst Date: 2013-09-16 Impact factor: 13.506
Authors: Lee W Jones; Benjamin L Viglianti; Jessica A Tashjian; Sejal M Kothadia; Stephen T Keir; Stephen J Freedland; Michael Q Potter; Eui Jung Moon; Thies Schroeder; James E Herndon; Mark W Dewhirst Journal: J Appl Physiol (1985) Date: 2009-12-03
Authors: Yiwey Shieh; Donglei Hu; Lin Ma; Scott Huntsman; Charlotte C Gard; Jessica W T Leung; Jeffrey A Tice; Celine M Vachon; Steven R Cummings; Karla Kerlikowske; Elad Ziv Journal: Breast Cancer Res Treat Date: 2016-08-26 Impact factor: 4.872
Authors: Mark Powell; Farid Jamshidian; Kate Cheyne; Joanne Nititham; Lee Ann Prebil; Rochelle Ereman Journal: Clin Breast Cancer Date: 2013-11-22 Impact factor: 3.225
Authors: Reena S Cecchini; Joseph P Costantino; Jane A Cauley; Walter M Cronin; D Lawrence Wickerham; Hanna Bandos; Joel L Weissfeld; Norman Wolmark Journal: Cancer Prev Res (Phila) Date: 2012-10-11